Rivaroxaban for prevention of thrombotic events, hospitalization, and death in outpatients with COVID-19: a randomized clinical trial
G Piazza, AC Spyropoulos, J Hsia, M Goldin… - Circulation, 2023 - Am Heart Assoc
Background: COVID-19 (coronavirus disease 2019) is associated with heightened risks of
venous and arterial thrombosis and hospitalization due to respiratory failure. To assess …
venous and arterial thrombosis and hospitalization due to respiratory failure. To assess …
Efficacy and safety of direct oral anticoagulants compared with heparin for preventing thromboembolism in hospitalized patients with COVID-19: a systematic review …
Y Tian, T Pan, X Wen, G Ao, Y Ma… - Clinical and Applied …, 2023 - journals.sagepub.com
A high rate of thromboembolism and a high risk of death have been reported regarding
hospitalized patients with coronavirus disease 2019 (COVID-19). Recently, we noticed that …
hospitalized patients with coronavirus disease 2019 (COVID-19). Recently, we noticed that …
Prognostic significance of the coagulation and complement systems in critical COVID-19 infection
A Ray, KAK Winter, DSL Naik, C Okorie - Prague Medical Report, 2023 - karolinum.cz
Infection with the SARS-CoV-2 virus (COVID-19 disease) can cause a wide range of clinical
situations–from an asymptomatic state to fatal outcomes. In cases of serious clinical …
situations–from an asymptomatic state to fatal outcomes. In cases of serious clinical …
Factor Xa inhibitors versus low molecular weight heparin for preventing coagulopathy following COVID-19: a systematic review and meta analysis of randomized …
L Amin, K Qayyum, M Uzair, F Khan… - Annals of Medicine …, 2024 - journals.lww.com
Background: Hospitalized patients with COVID-19 have shown a significant occurrence of
thromboembolism and a heightened risk of death. It remains unclear whether factor Xa …
thromboembolism and a heightened risk of death. It remains unclear whether factor Xa …
Anticoagulation in COVID-19 patients–An updated systematic review and meta-analysis
S Reis, A Faske, I Monsef, F Langer, OJ Müller… - Thrombosis …, 2024 - Elsevier
Background Thromboembolic events are common complications of COVID-19. Clinical study
results on safety and efficacy of anticoagulation in COVID-19 are controversial. Material and …
results on safety and efficacy of anticoagulation in COVID-19 are controversial. Material and …